Skip to main content

Abstract

Bone marrow transplantation is a complex procedure. However, the basic purpose is that of transferring normal lymphohemopoietic stem cells for lymphohemopoietic reconstitution, and to supply cells with normal genetic information central to metabolic pathways in the recipient organism. At present these functions are incompletely achieved. Consequently, the future of marrow transplantation will depend upon increasing the efficacy of these functions and lessening associated side effects. Quite likely the next generation of marrow transplantation will be different, in appearance, from the procedures used at the present time. The most important problems still to be mastered are those of recurrence of the underlying disease, prevention of GVHD without jeopardizing engraftment, prevention of infection and prevention of delayed adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andrews RG, Singer JW, Bernstein ID (1990) Human hematopoietic precursors in long term culture: single CD34+ cells that lack detectable T, B, and myeloid antigens produce multiple colony-forming cells when cultured with marrow stromal cells. J Exp Med 172:355–358

    Article  PubMed  CAS  Google Scholar 

  • Appelbaum FR (1989) The clinical use of hematopoietic growth factors. Semin Hematol 26:7–14

    PubMed  CAS  Google Scholar 

  • Badger CC, Bernstein ID (1989) Treatment of murine lymphoma with anti-thy 1.1 antibodies. In: Reif AE, Schlesinger M (eds), Thy-1: Immunology, Neurology, and Therapeutic Applications. Marcel Dekker, New York 515–529

    Google Scholar 

  • Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD, Bernstein ID (1988) Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951–955

    Article  PubMed  CAS  Google Scholar 

  • Culver K, Cornetta K, Morgan R, Morecki S, Aebersold P, Kasid A, Lotze M, Rosenberg SA, Anderson WF, Blaese RM (1991) Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci USA 88:3155–3159

    Article  PubMed  CAS  Google Scholar 

  • Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525–1533

    Article  PubMed  CAS  Google Scholar 

  • Hardy CL, Matsuoka T, Tavassoli M (1991) Distribution of homing protein on hemopoietic stromal and progenitor cells. Exp Hematol 19:968–972

    PubMed  CAS  Google Scholar 

  • Jalkanen S, Reichert RA, Gallatin WM, Bargatze RF, Weissman IL, Butcher EC (1986) Homing receptors and the control of lymphocyte migration. Immunol Rev 91:39–60

    Article  PubMed  CAS  Google Scholar 

  • Miller AD (1990) Progress toward human gene therapy. Blood 76:271–278

    PubMed  CAS  Google Scholar 

  • Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL, Merino MJ, Culver K, Miller AD, Blaese RM, Anderson WF (1990) Gene transfer into humans — immunotherapy of patients with advanced melanoma, using tumorinfiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323:570–578

    Article  PubMed  CAS  Google Scholar 

  • Spangrude GJ, Heimfeld S, Weissman IL (1988) Purification and characterization of mouse hematopoietic stem cells. Science 241:58–62

    Article  PubMed  CAS  Google Scholar 

  • Sykes M, Romick ML, Hoyles KA, Sachs DH (1990) In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment. J Exp Med 171:645–658

    Article  PubMed  CAS  Google Scholar 

  • Truitt RL, LeFever AV, Shih CCY, Jeske HM, Martin TM (1990) Graft-versus-leukemia effect. In: Burakoff SJ, Deeg HJ, Ferrara J, Atkinston K. (eds), Graft-versus-host disease: immunology, pathophysiology, and treatment. Marcel Dekker, New York 177–204

    Google Scholar 

  • Thomas ED (1990) Bone marrow transplantation — past, present and future. In: The Nobel Prizes. Stockholm, Sweden: The Nobel Foundation

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Deeg, H.J., Klingemann, HG., Phillips, G.L. (1992). Outlook. In: A Guide to Bone Marrow Transplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97374-1_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97374-1_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97376-5

  • Online ISBN: 978-3-642-97374-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics